top of page

Tinker Therapeutics
Our Development Pipeline
Tinker is advancing a pipeline of disease-modifying programs for Alzheimer's Disease and other neurological diseases in addition to partnered programs as part of strategic collaborations.

Note: Overview is illustrative of internal data, work plans, and research & development documentation as of August 2025.
* SCN1A NAT and SCN1A pre- mRNA splice site
** Subject to further licensing discussions and other collaboration technologies under review.
bottom of page